VollmerBLWallachAICorboyJR, et al. Serious safety events in rituximab-treated multiple sclerosis and related disorders. Ann Clin Transl Neurol2020; 7(9): 1477–1487.
2.
HauserSLKapposLMontalbanX, et al. Safety of ocrelizumab in patients with relapsing and primary progressive multiple sclerosis. Neurology2021; 97(16): e1546–e1559.
3.
Stogbauer, et al.
4.
McGillFGriffithsMJBonnettLJ, et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults: A multicentre prospective observational cohort study. Lancet Infect Dis2018; 18(9): 992–1003.
5.
DefresSTharmaratnamKMichaelBD, et al.; ENCEPH UK Study Group. Clinical predictors of encephalitis in UK adults: A multi-centre prospective observational cohort study. PLoS ONE2023;18: e0282645.
6.
ShenWCChiuHHChowKC, et al. MR imaging findings of enteroviral encephaloymelitis: An outbreak in Taiwan. AJNR Am J Neuroradiol1999; 20(10): 1889–1895.
